Literature DB >> 6680523

A critical level of diabetic autonomic neuropathy.

S Kageyama, I Taniguchi, S Tanaka, N Tajima, N Saito, Y Ikeda, M Abe.   

Abstract

Diabetic autonomic neuropathy was expressed quantitatively using the coefficient of variation of R-R intervals (CVR-R) in ECG and its critical level where diabetics were plagued with various symptoms was investigated. The subjects were 58 diabetics under the age of 40 years. ECGs were recorded in the resting supine position and the degree of autonomic neuropathy was expressed as CVR-R by processing 100 consecutive R-R intervals. Symptoms caused by diabetic autonomic neuropathy were determined using a questionnaire. CVR-R were 1.10 +/- 0.34% (mean +/- SD) and 4.31 +/- 2.01% in patients with and without orthostatic hypotension respectively, the former being significantly lower. CVR-R were 1.30 +/- 0.88% and 3.81 +/- 1.31% in those with and without impotence respectively, the former being significantly lower. CVR-R were 0.80 +/- 0.14% and 3.85 +/- 2.17% in those with and without diabetic diarrhea respectively, the former being significantly lower. Concerning sweating abnormality CVR-R were significantly reduced in subjects exhibiting gustatory sweating (1.52 +/- 0.74%) and hypohidrosis (2.26 +/- 1.44%) when compared to those without these symptoms. From the results obtained, a CVR-R of 2% can be considered as the critical level which determines whether symptoms due to diabetic autonomic neuropathy will appear or not.

Entities:  

Mesh:

Year:  1983        PMID: 6680523     DOI: 10.1620/tjem.141.suppl_479

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  10 in total

1.  Exploratory analysis using machine learning of predictive factors for falls in type 2 diabetes.

Authors:  Yasuhiro Suzuki; Hiroaki Suzuki; Tatsuya Ishikawa; Yasunori Yamada; Shigeru Yatoh; Yoko Sugano; Hitoshi Iwasaki; Motohiro Sekiya; Naoya Yahagi; Yasushi Hada; Hitoshi Shimano
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

2.  Relation of symptoms to impaired stomach, small bowel, and colon motility in long-standing diabetes.

Authors:  F L Iber; S Parveen; M Vandrunen; K B Sood; F Reza; R Serlovsky; S Reddy
Journal:  Dig Dis Sci       Date:  1993-01       Impact factor: 3.199

3.  Factors Associated with the Local Increase of Skin Temperature, 'Hotspot,' of Callus in Diabetic Foot: A Cross-Sectional Study.

Authors:  Qi Qin; Makoto Oe; Yumiko Ohashi; Yuko Shimojima; Mikie Imafuku; Misako Dai; Gojiro Nakagami; Toshimasa Yamauchi; SeonAe Yeo; Hiromi Sanada
Journal:  J Diabetes Sci Technol       Date:  2021-05-20

4.  Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report.

Authors:  Daisuke Matsutani; Masaya Sakamoto; Hiroyuki Iuchi; Souichirou Minato; Hirofumi Suzuki; Yosuke Kayama; Norihiko Takeda; Ryuzo Horiuchi; Kazunori Utsunomiya
Journal:  Cardiovasc Diabetol       Date:  2018-03-07       Impact factor: 9.951

5.  Postprandial Blood Pressure Decrease in Patients with Type 2 Diabetes and Mild or Severe Cardiac Autonomic Dysfunction.

Authors:  Masahiko Hashizume; Saori Kinami; Keiichi Sakurai; Kazuhiro P Izawa; Hideyuki Shiotani
Journal:  Int J Environ Res Public Health       Date:  2019-03-06       Impact factor: 3.390

6.  Power spectral analysis of heart rate variability is useful as a screening tool for detecting sympathetic and parasympathetic nervous dysfunctions in Parkinson's disease.

Authors:  Tomo Miyagi; Masanobu Yamazato; Takuto Nakamura; Takashi Tokashiki; Yukihiro Namihira; Kazuhito Kokuba; Satoshi Ishihara; Hirokuni Sakima; Yusuke Ohya
Journal:  BMC Neurol       Date:  2022-09-10       Impact factor: 2.903

7.  Alterations of retinal thickness measured by optical coherence tomography correlate with neurophysiological measures in diabetic polyneuropathy.

Authors:  Yuichiro Yamada; Tatsuhito Himeno; Kotaro Tsuboi; Yuka Shibata; Miyuka Kawai; Yuriko Asada-Yamada; Yusuke Hayashi; Emi Asano-Hayami; Tomohide Hayami; Yuichiro Ishida; Yohei Ejima; Mikio Motegi; Saeko Asano; Makoto Kato; Eriko Nagao; Hiromi Nakai-Shimoda; Takahiro Ishikawa; Yoshiaki Morishita; Masaki Kondo; Shin Tsunekawa; Yoshiro Kato; Takayuki Nakayama; Motohiro Kamei; Jiro Nakamura; Hideki Kamiya
Journal:  J Diabetes Investig       Date:  2020-12-30       Impact factor: 4.232

8.  Mealtime dosing of a rapid-acting insulin analog reduces glucose variability and suppresses daytime cardiac sympathetic activity: a randomized controlled study in hospitalized patients with type 2 diabetes.

Authors:  Takehiro Kanamori; Yumie Takeshita; Yuki Isobe; Ken-Ichiro Kato; Hirofumi Misu; Shuichi Kaneko; Toshinari Takamura
Journal:  BMJ Open Diabetes Res Care       Date:  2018-10-31

9.  Neuroretinal dysfunction revealed by a flicker electroretinogram correlated with peripheral nerve dysfunction and parameters of atherosclerosis in patients with diabetes.

Authors:  Miyuka Kawai; Tatsuhito Himeno; Yuka Shibata; Nobuhiro Hirai; Yuriko Asada-Yamada; Emi Asano-Hayami; Yohei Ejima; Rina Kasagi; Eriko Nagao; Yukako Sugiura-Roth; Hiromi Nakai-Shimoda; Takayuki Nakayama; Yuichiro Yamada; Takahiro Ishikawa; Yoshiaki Morishita; Masaki Kondo; Shin Tsunekawa; Yoshiro Kato; Jiro Nakamura; Hideki Kamiya
Journal:  J Diabetes Investig       Date:  2020-12-18       Impact factor: 4.232

10.  Point-of-care nerve conduction device predicts the severity of diabetic polyneuropathy: A quantitative, but easy-to-use, prediction model.

Authors:  Hideki Kamiya; Yuka Shibata; Tatsuhito Himeno; Hiroya Tani; Takayuki Nakayama; Kenta Murotani; Nobuhiro Hirai; Miyuka Kawai; Yuriko Asada-Yamada; Emi Asano-Hayami; Hiromi Nakai-Shimoda; Yuichiro Yamada; Takahiro Ishikawa; Yoshiaki Morishita; Masaki Kondo; Shin Tsunekawa; Yoshiro Kato; Masayuki Baba; Jiro Nakamura
Journal:  J Diabetes Investig       Date:  2020-09-14       Impact factor: 4.232

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.